Citadel Advisors - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 84 filers reported holding NEOS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$11,0000.0%18,200
-12.1%
0.00%
Q3 2020$11,000
-57.7%
20,705
-39.6%
0.00%
Q1 2020$26,000
+30.0%
34,271
+116.3%
0.00%
Q2 2019$20,000
-86.8%
15,845
-72.7%
0.00%
Q1 2019$152,000
+90.0%
58,112
+20.5%
0.00%
Q4 2018$80,000
-82.1%
48,234
-47.7%
0.00%
Q3 2018$448,000
+60.6%
92,206
+107.2%
0.00%
Q2 2018$279,000
+156.0%
44,498
+314.7%
0.00%
Q4 2017$109,000
-82.3%
10,730
-84.1%
0.00%
Q3 2017$617,000
+65.0%
67,442
+158.5%
0.00%
Q4 2015$374,00026,0870.00%
Other shareholders

There were no reported owners of NEOS THERAPEUTICS INC in Q4 2017.

NameSharesValueWeighting ↓
View complete list of NEOS THERAPEUTICS INC shareholders